Power spectral analysis of heart rate variability in rats as a quantitative tool in the PK-PD analysis of the parasympatholytic activity of atropine

Purpose. To utilize power spectral analysis (PSA) of heart rate variability (HRV) as a pharmacodynamic (PD) measure of atropine parasympathetic effect , and to model the kinetics of action. Methods. Heart rate data was collected following atropine administration to rats and was analyzed off-line for high frequency peaks by PSA of HRV as a measure of parasympathetic tone. A temporal cumulative approach (TCA) dete cted transient changes in parasympathetic activity. The pharmacokinetics (P K) was analyzed and linked to both direct and indirect PK-PD models. Results. TCA enabled a quantitative measure of atropine parasympathetic act ivity. A simultaneous fit of the indirect PK-PD model to the experimental d ata of all three atropine doses successfully captured the experimental data . Conclusions. TCA can be used as a quantitative measure of parasympathetic t one. Our work has established a preclinical model to investigate the kineti cs of drug action on the autonomic nervous system.